2019
$42M
from 4 investors over 4 rounds
Nucleome Therapeutics raised $42M on October 19, 2022
Investors: Oxford Sciences Innovation, British Patient Capital and M Ventures
Nucleome Therapeutics raised undisclosed on June 2, 2020
Investors: Creative Destruction Lab